Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS.

Chiu IM, Chen A, Zheng Y, Kosaras B, Tsiftsoglou SA, Vartanian TK, Brown RH Jr, Carroll MC.

Proc Natl Acad Sci U S A. 2008 Nov 18;105(46):17913-8. doi: 10.1073/pnas.0804610105.

2.

Effect of thymic stimulation of CD4+ T cell expansion on disease onset and progression in mutant SOD1 mice.

Sheean RK, Weston RH, Perera ND, D'Amico A, Nutt SL, Turner BJ.

J Neuroinflammation. 2015 Feb 27;12:40. doi: 10.1186/s12974-015-0254-3.

3.

Microglia and motor neurons during disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis: changes in arginase1 and inducible nitric oxide synthase.

Lewis KE, Rasmussen AL, Bennett W, King A, West AK, Chung RS, Chuah MI.

J Neuroinflammation. 2014 Mar 23;11:55. doi: 10.1186/1742-2094-11-55.

4.

Ablation of proliferating microglia does not affect motor neuron degeneration in amyotrophic lateral sclerosis caused by mutant superoxide dismutase.

Gowing G, Philips T, Van Wijmeersch B, Audet JN, Dewil M, Van Den Bosch L, Billiau AD, Robberecht W, Julien JP.

J Neurosci. 2008 Oct 8;28(41):10234-44. doi: 10.1523/JNEUROSCI.3494-08.2008.

5.

Spinal but not cortical microglia acquire an atypical phenotype with high VEGF, galectin-3 and osteopontin, and blunted inflammatory responses in ALS rats.

Nikodemova M, Small AL, Smith SM, Mitchell GS, Watters JJ.

Neurobiol Dis. 2014 Sep;69:43-53. doi: 10.1016/j.nbd.2013.11.009.

6.

Spinal cord pathology is ameliorated by P2X7 antagonism in a SOD1-mutant mouse model of amyotrophic lateral sclerosis.

Apolloni S, Amadio S, Parisi C, Matteucci A, Potenza RL, Armida M, Popoli P, D'Ambrosi N, Volonté C.

Dis Model Mech. 2014 Sep;7(9):1101-9. doi: 10.1242/dmm.017038.

7.

Influence of methylene blue on microglia-induced inflammation and motor neuron degeneration in the SOD1(G93A) model for ALS.

Dibaj P, Zschüntzsch J, Steffens H, Scheffel J, Göricke B, Weishaupt JH, Le Meur K, Kirchhoff F, Hanisch UK, Schomburg ED, Neusch C.

PLoS One. 2012;7(8):e43963. doi: 10.1371/journal.pone.0043963.

8.

Transcriptional profiling in the lumbar spinal cord of a mouse model of amyotrophic lateral sclerosis: a role for wild-type superoxide dismutase 1 in sporadic disease?

D'Arrigo A, Colavito D, Peña-Altamira E, Fabris M, Dam M, Contestabile A, Leon A.

J Mol Neurosci. 2010 Jul;41(3):404-15. doi: 10.1007/s12031-010-9332-2. Erratum in: J Mol Neurosci. 2010 Jul;41(3):416.

PMID:
20177826
9.

Granulocyte colony stimulating factor attenuates inflammation in a mouse model of amyotrophic lateral sclerosis.

Pollari E, Savchenko E, Jaronen M, Kanninen K, Malm T, Wojciechowski S, Ahtoniemi T, Goldsteins G, Giniatullina R, Giniatullin R, Koistinaho J, Magga J.

J Neuroinflammation. 2011 Jun 28;8:74. doi: 10.1186/1742-2094-8-74.

10.

Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis.

Beers DR, Henkel JS, Zhao W, Wang J, Huang A, Wen S, Liao B, Appel SH.

Brain. 2011 May;134(Pt 5):1293-314. doi: 10.1093/brain/awr074.

11.

The omega-3 fatty acid eicosapentaenoic acid accelerates disease progression in a model of amyotrophic lateral sclerosis.

Yip PK, Pizzasegola C, Gladman S, Biggio ML, Marino M, Jayasinghe M, Ullah F, Dyall SC, Malaspina A, Bendotti C, Michael-Titus A.

PLoS One. 2013 Apr 19;8(4):e61626. doi: 10.1371/journal.pone.0061626.

12.

Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice.

Banerjee R, Mosley RL, Reynolds AD, Dhar A, Jackson-Lewis V, Gordon PH, Przedborski S, Gendelman HE.

PLoS One. 2008 Jul 23;3(7):e2740. doi: 10.1371/journal.pone.0002740.

13.

Effects of the PPARgamma activator pioglitazone on p38 MAP kinase and IkappaBalpha in the spinal cord of a transgenic mouse model of amyotrophic lateral sclerosis.

Shibata N, Kawaguchi-Niida M, Yamamoto T, Toi S, Hirano A, Kobayashi M.

Neuropathology. 2008 Aug;28(4):387-98. doi: 10.1111/j.1440-1789.2008.00890.x.

PMID:
18312546
14.

Immune reactivity in a mouse model of familial ALS correlates with disease progression.

Alexianu ME, Kozovska M, Appel SH.

Neurology. 2001 Oct 9;57(7):1282-9.

PMID:
11591849
15.

Deleterious effects of lymphocytes at the early stage of neurodegeneration in an animal model of amyotrophic lateral sclerosis.

Tada S, Okuno T, Yasui T, Nakatsuji Y, Sugimoto T, Kikutani H, Sakoda S.

J Neuroinflammation. 2011 Feb 23;8:19. doi: 10.1186/1742-2094-8-19.

16.
17.

Ablation of proliferating cells in the CNS exacerbates motor neuron disease caused by mutant superoxide dismutase.

Audet JN, Gowing G, Paradis R, Soucy G, Julien JP.

PLoS One. 2012;7(4):e34932. doi: 10.1371/journal.pone.0034932.

18.

Dismutase-competent SOD1 mutant accumulation in myelinating Schwann cells is not detrimental to normal or transgenic ALS model mice.

Turner BJ, Ackerley S, Davies KE, Talbot K.

Hum Mol Genet. 2010 Mar 1;19(5):815-24. doi: 10.1093/hmg/ddp550.

19.

Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice.

Butovsky O, Jedrychowski MP, Cialic R, Krasemann S, Murugaiyan G, Fanek Z, Greco DJ, Wu PM, Doykan CE, Kiner O, Lawson RJ, Frosch MP, Pochet N, Fatimy RE, Krichevsky AM, Gygi SP, Lassmann H, Berry J, Cudkowicz ME, Weiner HL.

Ann Neurol. 2015 Jan;77(1):75-99. doi: 10.1002/ana.24304. Erratum in: Ann Neurol. 2015 Jun;77(6):1085.

20.

In Vivo imaging reveals distinct inflammatory activity of CNS microglia versus PNS macrophages in a mouse model for ALS.

Dibaj P, Steffens H, Zschüntzsch J, Nadrigny F, Schomburg ED, Kirchhoff F, Neusch C.

PLoS One. 2011 Mar 18;6(3):e17910. doi: 10.1371/journal.pone.0017910.

Items per page

Supplemental Content

Support Center